Growth Works supports Paragraf to make wonder material
Cambridge-based Paragraf, which makes ‘wonder material’ used in cars and medical diagnostics, is urging other companies to team up with Growth Works – an organisation that helped it win a £150k grant to scale the business.
Manchester spin-out that looks to revolutionise water filtration gets £500,000 funding boost
A spin-out company based at The University of Manchester that is developing a breakthrough water filtration technology, which promises to be both greener and cheaper, has secured SEED equity investment of £500,000 to help scale up.
LegalTech Apperio raises £5.75m in latest funding round
Hambro Perks has invested £2m into the London-based firm, which works with more than 60 in-house legal teams
PhoreMost taps milestone goldmine with German pharma client
Cambridge biopharma trailblazer PhoreMost, has triggered a lucrative but unspecified milestone payment in a multi-project target discovery collaboration with German giant Boehringer Ingelheim. It promises to be the first of many as the alliance rolls out.
CTO Sessions: William Jones, Sano Genetics
William Jones is co-founder of healthtech startup Sano Genetics, a medical research technology startup he founded with two fellow genomics students who he met while studying as a PhD student at the University of Cambridge.
New CTO for Sphere Fluidics
Sphere Fluidics, a Cambridge company developing single cell analysis systems, has appointed Richard Hammond as Chief Technical Officer.
Qkine raises £4.3m scale-up capital and prepares HQ move
Qkine, a Cambridge manufacturer of animal-free, highly bioactive and innovative proteins and growth factors for life science applications, has closed a £4.3 million oversubscribed funding round.
PhoreMost and ThinkCyte partner to develop AI-based drug discovery
The partnership combines systems in order to identify subtle phenotypic changes in living cells.
MicrofluidX raises £3.3M to develop advanced therapy manufacturing platform
MicrofluidX (MFX), a U.K. based provider of next-generation bioreactors for cell research and manufacturing, has announced £3.3 million ($4 million) of secured investments. This brings the company’s total funding to date to £7 million ($8.5 million).
Thought Machine signs Brazillian digital bank C6
C6 Bank, a full-service bank for individuals and businesses based in São Paulo, Brazil, today announces it will be using core banking technology from Thought Machine for innovative products, which will be announced shortly.
RareCan selected for Francis Crick Institute KQ Labs data-driven health accelerator programme
RareCan, the UK’s only health tech company that specialises in supporting people with rare cancers, has been selected to join the prestigious KQ Labs programme run by the world renowned Francis Crick Institute in London. KQ Labs is an accelerator programme for exciting early-stage start-ups using data as a core part of their business model to improve human health.
Nova Pangaea sets up base at Sembcorp's Wilton site
A clean technology firm has signed an agreement to base its new commercial plant and headquarters within the Teesside Freeport.
Snaile to trial end-to-end label free technology
Canada’s largest smart locker network, Snaile, has contracted Stamp Free to begin a trial of its fully end-to-end label-free technology to provide a convenient, sustainable label-free and cost-saving method of sending parcels and returns.
Thought Machine’s core banking system to “reinvent” Payset
UK-based paytech Payset is implementing a new core banking system, Vault Core, provided by fellow UK tech company Thought Machine, to underpin its international payments platform.
NHS Grampian is working with Kheiron Medical Technologies, University of Aberdeen and Microsoft to support breast cancer detection
NHS Grampian, which provides health and social care services to more than 500,000 people in Scotland, is trialling Kheiron Medical Technologies’ artificial intelligence to help medical staff detect cancer, cut the backlog of mammograms to be read and deliver results to patients faster.
Cancer patients to help trial ‘life saving’ home testing kit
Addenbrooke’s hospital is helping to trial a new home-testing device to check if cancer patients are at risk from a serious side effect of chemotherapy.
RoboK AI helps power crucial UK drones project
AI technology from Cambridge University spin-out RoboK is playing a key role in arguably the most significant drones project witnessed to date in the UK.
Teesside's Nova Pangaea Technologies secures investment from British Airways parent IAG
The clean tech firm's latest deal follows recent £5.2m investment from a group of backers
Stemnovate creates neurons from skin cells of dogs, cats and horses to reduce need for animal testing
Stemnovate has created neurons from the skin cells of dogs, cats and horses in what is thought to be a world first.
Arecor announces exclusive specialty hospital formulation collaboration
Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed an exclusive formulation study collaboration with the pharmaceutical division of one of the world’s largest chemicals marketing and pharmaceuticals companies, which focuses on the development and commercialisation of speciality drugs.